Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to ...

Lundbeck stopped pursuing Tourette, an indication an exec later called “a little optimistic,” in 2020 but kept going after conditions in which it believed MAGL inhibition was a better fit.